Literature DB >> 7510688

Two alternatively spliced forms of the human insulin-like growth factor I receptor have distinct biological activities and internalization kinetics.

G Condorelli1, R Bueno, R J Smith.   

Abstract

Two alternatively spliced human insulin-like growth factor I (IGF I) receptor mRNA transcripts have been described that differ by three nucleotides (CAG) starting at position 2829. This results in an amino acid coding sequence change from Thr-Gly to Arg in the extracellular portion of the receptor beta subunit. To investigate the functional significance of this sequence difference, we obtained full-length cDNAs for the CAG+ and CAG- receptor forms, transfected CHO cells, and isolated multiple clones expressing approximately equal numbers of receptors (0.57-0.73 x 10(6) receptors/cell). The two receptors bound IGF I with similar affinity (Kd approximately 1.7 nM), but the CAG- form exhibited an approximately 2-fold increase in IGF I stimulation of receptor autophosphorylation, insulin receptor substrate-1 (IRS-1) tyrosine phosphorylation, thymidine incorporation, and IRS-1-associated phosphatidylinositol 3-kinase activity. In contrast to its higher signaling activity, the rate of receptor-mediated internalization of IGF I by the CAG-receptor was decreased by 50% in comparison with the CAG+ receptor. We conclude that proteins corresponding to the two alternatively spliced human IGF I receptor transcripts are biologically active, but have distinct signaling properties. These experiments further indicate a previously unrecognized role for the extramembranous portion of the beta subunit in receptor signaling and internalization.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7510688

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Insulin-like growth factors I and II receptors in the breast cancer survival disparity among African-American women.

Authors:  S Kalla Singh; Q W Tan; C Brito; M De León; D De León
Journal:  Growth Horm IGF Res       Date:  2010-03-27       Impact factor: 2.372

2.  Single-nucleotide polymorphisms in NAGNAG acceptors are highly predictive for variations of alternative splicing.

Authors:  Michael Hiller; Klaus Huse; Karol Szafranski; Niels Jahn; Jochen Hampe; Stefan Schreiber; Rolf Backofen; Matthias Platzer
Journal:  Am J Hum Genet       Date:  2005-12-22       Impact factor: 11.025

3.  Assessing the fraction of short-distance tandem splice sites under purifying selection.

Authors:  Michael Hiller; Karol Szafranski; Rileen Sinha; Klaus Huse; Swetlana Nikolajewa; Philip Rosenstiel; Stefan Schreiber; Rolf Backofen; Matthias Platzer
Journal:  RNA       Date:  2008-02-11       Impact factor: 4.942

Review 4.  Kinase inhibitors in cancer therapy: a look ahead.

Authors:  H H Sedlacek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

5.  Analysis of a peptide hormone-receptor interaction in the yeast two-hybrid system.

Authors:  J Zhu; C R Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

6.  Genome-wide study of NAGNAG alternative splicing in Arabidopsis.

Authors:  Yanjing Shi; Guangli Sha; Xiaoyong Sun
Journal:  Planta       Date:  2013-10-06       Impact factor: 4.116

Review 7.  Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy.

Authors:  N Muge Kuyumcu-Martinez; Thomas A Cooper
Journal:  Prog Mol Subcell Biol       Date:  2006

8.  Insulin-like growth factor-1 receptor-targeted therapy for non-small cell lung cancer: a mini review.

Authors:  Ming Yin; Xiaoxiang Guan; Zhongxin Liao; Qingyi Wei
Journal:  Am J Transl Res       Date:  2009-01-30       Impact factor: 4.060

9.  Sequence features involved in the mechanism of 3' splice junction wobbling.

Authors:  Kuo-Wang Tsai; Wen-Ching Chan; Chun-Nan Hsu; Wen-Chang Lin
Journal:  BMC Mol Biol       Date:  2010-05-07       Impact factor: 2.946

10.  Molecular determinants and evolutionary dynamics of wobble splicing.

Authors:  Jianning Lv; Yun Yang; Heng Yin; Fengjiao Chu; Haitao Wang; Wenjing Zhang; Yaozhou Zhang; Yongfeng Jin
Journal:  Mol Biol Evol       Date:  2009-02-12       Impact factor: 16.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.